Bookmark

Add to MyYahoo RSS

PDL BioPharma News

News on PDL BioPharma (Ticker: PDLI) continually updated from thousands of sources around the net.

Monday Apr 7 | BioSpace

Kaleo Announces $150 Million Debt Financing To Support Commercialization Of EVZIO

Under the financing, PDL provided in cash at closing and will receive interest on the principal outstanding.

Comment?

Related Topix: Startups

Tue Apr 01, 2014

AmericanBankingNews.com

PDL BioPharma Sees Significant Decrease in Short Interest

Shares of PDL BioPharma saw a significant decrease in short interest during the month of January.

Comment?

Related Topix: Startups

Sat Mar 22, 2014

Hispanic Business

PDL BioPharma Updates on First Quarter 2014 Revenue Guidance of $133M

Pursuant to the Settlement Agreement, and Roche confirmed that Avastin, Herceptin, Lucentis, Xolair and Perjeta are licensed products as defined in the relevant license agreements between the parties, and further agreed that Kadcyla and Gazyva are licensed products.

Comment?

Related Topix: Startups

Thu Mar 20, 2014

Sys-Con Media

Momentum Indicators for Health Care Equities -- Research on Arena...

The losses were broad based as all the sectors ended the session in negative. The S&P 500 Health Care Sector Index finished the day at 686.44, down 0.37%, while the same has advanced 1.72% in the previous three trading sessions.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Startups, Celgene

Mon Mar 17, 2014

The Motley Fool

5 Reasons to Buy PDL BioPharma Inc

The wisdom of investing in stocks that pay dividends will never go out of style.

Comment?

Related Topix: Startups, Science / Technology, Inventions

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••